Table 2 Measurement domains and data collection methods
Data-abstraction from sampled medical records | Interview and questionnaire for contact persons in the practice | Survey in CHD patients | Survey in high risk patients | Survey in healthy patients | |
|---|---|---|---|---|---|
1. Clinical and organisational performance in cardiovascular prevention (= EPA Cardio instrument) | X | X | |||
2. Engagement of the practice in quality improvement projects | X | ||||
3 Practice characteristics, including EPA dimensions | X | ||||
4a Patient demographics and chronic diseases | X | X | X | ||
4b PACIC | X | ||||
4c. EQ-5D | X | X | |||
4d EUROPEP | X | X | X | ||
4e Lifestyle: smoking, physical exercise, diet | X | X | |||
5 Views on primary primary prevention in general practice | X | X |